Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.18632/aging.103449

http://scihub22266oqcxt.onion/10.18632/aging.103449
suck pdf from google scholar
32534451!7346079!32534451
unlimited free pdf from europmc32534451    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32534451 :   free

suck abstract from ncbi

pmid32534451
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19? #MMPMID32534451
  • Viel T; Chinta S; Rane A; Chamoli M; Buck H; Andersen J
  • Aging (Albany NY) 2020[Jun]; 12 (11): 10035-10040 PMID32534451show ga
  • Cell senescence is a process that causes growth arrest and the release of a senescence associated secretory phenotype (SASP), characterized by secretion of chemokines, cytokines, cell growth factors and metalloproteases, leading to a tissue condition that may precipitate cancers and neurodegenerative processes. With the recent pandemic of coronavirus, senolytic drugs are being considered as possible therapeutic tools to reduce the virulence of SARS-CoV-2. In the last few years, our research group showed that lithium carbonate at microdose levels was able to stabilize memory and change neuropathological characteristics of Alzheimer's disease (AD). In the present work, we present evidence that low-dose lithium can reduce the SASP of human iPSCs-derived astrocytes following acute treatment, suggesting that microdose lithium could protect cells from senescence and development of aging-related conditions. With the present findings, a perspective of the potential use of low-dose lithium in old patients from the "high risk group" for COVID-19 (with hypertension, diabetes and chronic obstructive pulmonary disease) is presented.
  • |Astrocytes/*drug effects[MESH]
  • |Cells, Cultured[MESH]
  • |Coronavirus Infections/*drug therapy[MESH]
  • |Drug Evaluation, Preclinical[MESH]
  • |Humans[MESH]
  • |Lithium Compounds/*therapeutic use[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*drug therapy[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    10035 11.12 2020